MDxHealth Q1 2024 GAAP EPS $(0.31) Misses $(0.30) Estimate, Sales $19.834M Beat $18.209M Estimate
Portfolio Pulse from Benzinga Newsdesk
MDxHealth (NASDAQ:MDXH) reported Q1 2024 earnings with a GAAP EPS of $(0.31), missing the $(0.30) estimate by 3.33%, but sales of $19.834M exceeded the $18.209M estimate by 8.92%, marking a 34.93% increase from the previous year.
May 01, 2024 | 11:49 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MDxHealth reported a Q1 2024 GAAP EPS of $(0.31), missing estimates by 3.33%, but sales of $19.834M exceeded expectations by 8.92%, a 34.93% increase YOY.
The mixed results with a slight miss in EPS but a significant beat in sales revenue could lead to neutral short-term stock price movement. The sales growth indicates strong business performance, potentially offsetting the negative impact of the EPS miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100